Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard site header and footer, indicating the study record is not accessible. The previously visible study content and documents appear to be removed or hidden, leaving only navigation and site chrome.SummaryDifference18%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label changed from Revision: v3.6.5 to Revision: v3.6.6. This indicates deployment of a newer build of the page.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4. This update indicates a minor version change in the page history and does not modify the displayed study details.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3 label. This indicates a small backend/UI update without changing the study content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a recent software or content revision of the ClinicalTrials.gov page.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new deployment of the study record page; the change does not modify the study details presented.SummaryDifference0.0%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.